Trial · NCT00517556
Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
NCT00517556, Phase 1, Phase 2, Completed, Milton S. Hershey Medical Center; results first posted 2017-04-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea. Trials, record NCT00517556. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00517556
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
- NCT number
- NCT00517556
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 38 participants, actual
- Lead sponsor
- Milton S. Hershey Medical Center
- Conditions
- Dysmenorrhea
- Interventions
- CCOCP, Traditional OCP
- First posted
- 2007-08-17
- Last updated
- 2017-04-28
- Results first posted
- 2017-04-28
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Visual Analog Scale (VAS) Score | Baseline and 6 months | Change in subjective perception of pain, as measured by the VAS. Subjects completed the VAS at baseline and 6 months. The VAS ranges from 0 (no pain) to 100 (worst pain). Therefore, a negative change in VAS indicates improvement in pain and a positive change in VAS indicates worsening of pain. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Visual Analog Scale (VAS) Score | Baseline and 6 months | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Visual Analog Scale (VAS) Score | Study Group (CCOCP) | -74.8 | 95% Confidence Interval -86.1 to -63.5 | units on a scale | |
| Change in Visual Analog Scale (VAS) Score | Control Group (Traditional OCP) | -58.7 | 95% Confidence Interval -70.3 to -47.2 | units on a scale |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Study Group (CCOCP) | 19 | |
| Overall Study | STARTED | Control Group (Traditional OCP) | 19 | |
| Overall Study | COMPLETED | Study Group (CCOCP) | 15 | |
| Overall Study | COMPLETED | Control Group (Traditional OCP) | 14 | |
| Overall Study | NOT COMPLETED | Study Group (CCOCP) | 4 | |
| Overall Study | NOT COMPLETED | Control Group (Traditional OCP) | 5 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Study Group (CCOCP) | 0 | 19 |
| Total, all-cause mortality | Control Group (Traditional OCP) | 0 | 19 |
| Total, other adverse events | Study Group (CCOCP) | 0 | 19 |
| Total, other adverse events | Control Group (Traditional OCP) | 0 | 19 |
| Total, serious adverse events | Study Group (CCOCP) | 0 | 19 |
| Total, serious adverse events | Control Group (Traditional OCP) | 0 | 19 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Study Group (CCOCP) vs Control Group (Traditional OCP): deaths from any cause | Trial comparisons |
| Study Group (CCOCP) vs Control Group (Traditional OCP): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00517556
GET https://conductscience.org/api/trials/v1/NCT00517556/registered